首页 正文

PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology

{{output}}
The field of cardio-oncology is an expanding frontier within cardiovascular medicine, and the need for evidence-based guidelines is apparent. One of the emerging focuses within cardio-oncology is the concomitant use of medications for cardioprotection in the s... ...